CAY10505 in (ML246) Talukdar S

Talukdar S

Treatment of diet-induced obese mice with SR9009 decreased obesity by reducing fat mass and markedly improved dyslipidaemia and hyperglycaemia

and (3) kidney transplantation

Administration of GKT137831 throughout the 72-hour period of normoxia or hypoxia exposure attenuates HPASMC proliferation under normoxic conditions at the 20 μM concentration but had no effect on proliferation in normoxic HPAECs

CAY10505 in (ML246) Talukdar SCAY10505 is a phosphatidylinositol 3 kinase inhibitor , was found to significantly improve acetylcholine induced endothelium dependent relaxation, serum nitrate and (or) nitrite level, glutathione level, and the vascular endothelial lining in hypertensive rats. CAY10505 , may improve hypertension associated vascular endothelial dysfunction. Inhibition of PI3K might be a useful approach in the therapeutics of vascular endothelium dysfunction. Product